/NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S.
WIRE SERVICES/
WINNIPEG, July 5, 2018 /CNW/ - DELTA 9 CANNABIS INC. (TSXV:
NINE) ("Delta 9" or the "Company") is pleased to announce that it
has retained Hybrid Financial Inc. ("Hybrid") to provide investor
relations services to the Company. The services will include
marketing and branding initiatives focused on raising market
awareness of the Company and increasing the Company's profile with
investment advisors in the United
States and Canada.
Pursuant to the terms of the agreement entered into between the
Company and Hybrid (the "Agreement"), Hybrid will receive a monthly
retainer of $14,000 and a one-time
issuance of 250,000 incentive stock options (the "Options"), each
exercisable to acquire one common share of Delta 9 at an exercise
price of $1.49 per share upon vesting
and for a period expiring on the earlier of five years from the
date of grant and 3 months following the termination of the
Agreement.
The Options shall vest in four equal tranches over a 12 month
period, with 62,500 Options (25%) vesting at the end of each three
month period following the date of grant. The Agreement is for an
initial term of three months commencing July
4, 2018 and shall automatically be renewed on a
month-to-month basis, unless and until terminated by the Company by
providing 15 days' notice prior to the end of the initial or
renewed term, as the case may be.
The Agreement remains subject to the approval of the TSX Venture
Exchange.
Except with respect to the Options and any common shares of
Delta 9 that may be issued upon the exercise thereof, Hybrid does
not have any interest, directly or indirectly, in the Company or
its securities, or any right or intent to acquire such an
interest.
Hybrid is a privately held company majority owned by a company
controlled by its co-founder and managing director, Alexandre Côté,
a former managing director of AXA Canada and VP of sales at OpenSky
Capital. Founded in 2011, Hybrid describes its team as consisting
of over 40 sales professionals and 70 sales call agents operating
in Toronto and Montreal.
About Delta 9 Cannabis Inc.
Delta 9's wholly-owned
subsidiary, Delta 9 Bio-Tech Inc., is a licensed producer of
medical marijuana pursuant to the ACMPR and operates an 80,000
square foot production facility in Winnipeg, Manitoba, Canada. Delta 9's shares
trade on the TSX Venture Exchange under the symbol "NINE".
Neither the TSX Venture Exchange nor its Regulation
Services Provider (as that term is defined in the policies of the
TSX Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
Disclaimer for Forward-Looking Information
Certain statements in this release are forward-looking
statements, which reflect the expectations of management regarding
the Company's future business plans and other matters.
Forward-looking statements consist of statements that are not
purely historical, including any statements regarding beliefs,
plans, expectations or intentions regarding the future. Forward
looking statements in this news release include statements relating
to the services to be provided by Hybrid under the Agreement. Such
statements are subject to risks and uncertainties that may cause
actual results, performance or developments to differ materially
from those contained in the statements, including the risk that the
services to be provided by Hybrid will differ from those set out in
the Agreement. No assurance can be given that any of the events
anticipated by the forward-looking statements will occur or, if
they do occur, what benefits the Company will obtain from them.
Readers are urged to consider these factors carefully in evaluating
the forward-looking statements contained in this news release and
are cautioned not to place undue reliance on such forward-looking
statements, which are qualified in their entirety by these
cautionary statements. These forward-looking statements are made as
of the date hereof and the Company disclaims any intent or
obligation to update publicly any forward-looking statements,
whether as a result of new information, future events or results or
otherwise, except as required by applicable securities
laws.
SOURCE Delta 9 Cannabis Inc.